Intimacypedia

Facts only, sources on every article, written for all bodies. Anyone can improve a page.

U=U: undetectable equals untransmittable

The evidence that effective HIV treatment prevents sexual transmission entirely.

Edit this article History (1)Last updated 8/19/2026

The statement

A person living with HIV who is on effective antiretroviral treatment, with a viral load consistently suppressed below 200 copies per millilitre, cannot transmit HIV sexually. Not low risk — zero recorded transmissions across the trials that tested it.

The evidence

HPTN 052 (Cohen et al., 2011, NEJM) randomised 1,763 serodifferent couples, mostly heterosexual, to early or delayed antiretroviral therapy. Early treatment reduced linked transmission by 96 percent. The trial was stopped early on ethical grounds because the benefit was so clear. The final analysis found no linked transmissions from participants with durable viral suppression.

PARTNER (Rodger et al., 2016, JAMA) followed 888 serodifferent couples, both same-sex and opposite-sex, through around 58,000 acts of condomless sex where the partner with HIV was virally suppressed. Zero phylogenetically linked transmissions.

PARTNER2 (Rodger et al., 2019, Lancet) extended this specifically to gay male couples: 782 couples, roughly 76,000 acts of condomless anal sex, eight years of follow-up. Zero linked transmissions.

Opposites Attract (Bavinton et al., 2018, Lancet HIV) followed 343 male serodifferent couples in Australia, Thailand and Brazil through nearly 17,000 acts of condomless anal sex. Zero linked transmissions.

Across these studies, roughly 130,000 acts of condomless sex with a virally suppressed partner produced no transmissions. This is one of the most robust findings in HIV science.

What it requires

  • Sustained suppression. Guidance generally means at least six months of an undetectable result and continued adherence.
  • Ongoing adherence and monitoring. Missing doses allows viral rebound. Regular viral load testing confirms suppression.
  • The threshold is under 200 copies/mL, which is the figure used in the trials. Most assays report undetectable below 20–50.

Blips — occasional low-level detectable results — are common and do not by themselves mean transmission risk returns; sustained rebound does. Discuss any detectable result with the treating team rather than assuming either way.

What it does not cover

U=U applies to sexual transmission. It does not apply to:

  • Other STIs, which transmit normally.
  • Pregnancy.
  • Sharing injecting equipment, where evidence is not established.
  • Breastfeeding, where risk is greatly reduced but not established as zero; guidance varies by country and by access to safe formula feeding.

Vertical transmission during pregnancy and birth is reduced to under 1 percent with treatment and appropriate delivery management.

Why it matters beyond transmission

U=U is endorsed by WHO, CDC, UNAIDS, BHIVA, EACS and over 1,000 organisations worldwide. Its significance is not only clinical.

  • It removes the basis for treating people with HIV as inherently infectious, which is the foundation of most HIV stigma.
  • It undermines the rationale for HIV criminalisation laws, many of which predate the evidence and remain in force.
  • It improves treatment engagement: knowing that adherence protects partners is a strong and well-documented motivator.
  • It changes disclosure conversations from risk warnings to statements of fact.

Testing and treatment access are therefore prevention infrastructure. An undiagnosed infection cannot be suppressed, and acute early infection — before diagnosis — carries the highest viral loads and accounts for a disproportionate share of onward transmission.

Sources

  • Cohen MS et al. "Prevention of HIV-1 infection with early antiretroviral therapy (HPTN 052)." NEJM, 2011; and final results, 2016.
  • Rodger AJ et al. "Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy (PARTNER)." JAMA, 2016.
  • Rodger AJ et al. "Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER2)." Lancet, 2019.
  • Bavinton BR et al. "Viral suppression and HIV transmission in serodiscordant male couples (Opposites Attract)." Lancet HIV, 2018.
  • CDC. "Evidence of HIV treatment and viral suppression in preventing the sexual transmission of HIV." Dear Colleague letter and current guidance.
  • WHO. "The role of HIV viral suppression in improving individual health and reducing transmission." Policy brief, 2023.

Last reviewed: August 2026.

Educational reference, not medical advice. Every article is community-edited and cites its sources; verify anything that affects your health with a clinician who knows your history.